Mesothelioma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action ...
DelveInsight’s, “Mesothelioma Pipeline Insight 2025” report provides comprehensive insights about 45+ companies and 50+ ...
CStone doses first subject in trial of CS2009 for advanced solid tumours
The antibody has shown promising results in preclinical studies, demonstrating 'superior' anti-tumour activity.